Validation of phospholipase A2 receptor direct immunofluorescence staining in the diagnosis of primary membranous glomerulonephritis

P Dai, D Campbell, S Culican, DA Brown, K Byth… - Pathology, 2020 - Elsevier
Distinguishing between primary and secondary subtypes of membranous
glomerulonephritis (MGN) is critical for its clinical management. We prospectively compared …
被引用次数：3 相关文章

Validation of phospholipase A2 receptor direct immunofluorescence staining in the diagnosis of primary membranous glomerulonephritis

P Dai, D Campbell, S Culican, DA Brown… - …, 2020 - pathologyjournal.rcpa.edu.au
Distinguishing between primary and secondary subtypes of membranous
glomerulonephritis (MGN) is critical for its clinical management. We prospectively compared …

Validation of phospholipase A2 receptor direct immunofluorescence staining in the diagnosis of primary membranous glomerulonephritis.

P Dai, D Campbell, S Culican, DA Brown, K Byth… - Pathology, 2020 - europepmc.org
Distinguishing between primary and secondary subtypes of membranous
glomerulonephritis (MGN) is critical for its clinical management. We prospectively compared …

Validation of phospholipase A2 receptor direct immunofluorescence staining in the diagnosis of primary membranous glomerulonephritis

P Dai, D Campbell, S Culican, DA Brown… - …, 2020 - pubmed.ncbi.nlm.nih.gov
Distinguishing between primary and secondary subtypes of membranous
glomerulonephritis (MGN) is critical for its clinical management. We prospectively compared …

Validation of phospholipase A 2 receptor direct immunofluorescence staining in the diagnosis of primary membranous glomerulonephritis

P Dai, D Campbell, S Culican, DA Brown, K Byth… - 2020 - wslhd.intersearch.com.au
Distinguishing between primary and secondary subtypes of membranous
glomerulonephritis (MGN) is critical for its clinical management. We prospectively compared …